Nelarabine-induced rhabdomyolysis in a patient with T-cell acute lymphoblastic leukemia: a case report

BACKGROUND: Nelarabine is an antineoplastic purine analog used for the treatment of refractory or relapsed T-cell acute lymphoblastic leukemia (T-ALL). The most prominent side effect of nelarabine are neurotoxicity and hematologic disorder, which are considered dose-limiting factors. Although clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Utsumi, Akari, Goto, Yuri, Suzuki, Takaaki, Imai, Chiaki, Matsui, Shinichiro, Sakaida, Emiko, Ishii, Itsuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188041/
https://www.ncbi.nlm.nih.gov/pubmed/35690835
http://dx.doi.org/10.1186/s40780-022-00247-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188041/
https://www.ncbi.nlm.nih.gov/pubmed/35690835
http://dx.doi.org/10.1186/s40780-022-00247-w

Ejemplares similares